Telmisartan, ramipril, or both in patients at high risk of vascular events

N Engl J Med. 2008 Jul 24;359(4):426-7; author reply 427.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angioedema / chemically induced
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Benzimidazoles / adverse effects*
  • Benzoates / adverse effects*
  • Cardiovascular Diseases / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Hypotension / chemically induced
  • Ramipril / adverse effects*
  • Telmisartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Ramipril
  • Telmisartan